Blog In Vitro Studies

In Vitro Cytotoxicity in Balb/c 3T3 LD50 (OECD 129)

In Vitro Cytotoxicity in Balb/c 3T3 LD50 (OECD 129) The in vitro cytotoxicity assay in Balb/c 3T3 cells with an...

January 16, 20244 Min read
Read More

Study Design of In Vitro Skin Absorption: Franz Cell Diffusion Assay (OECD 428)

Study Design of In Vitro Skin Absorption: Franz Cell Diffusion Assay (OECD 428) The Franz Cell Diffusion Assay (OECD 428)...

January 16, 20244 Min read
Read More

In Vitro Skin Sensitization [Human Cell Line (U937-U-SENS) Activation Test (h-CLAT)] (OECD 442E)

In Vitro Skin Sensitization [Human Cell Line (U937-U-SENS) Activation Test (h-CLAT)] (OECD 442E) The Human Cell Line Activation Test (h-CLAT)...

January 16, 20244 Min read
Read More

Study Design of In Vitro Skin Sensitization – ARE-Nrf2 Luciferase Test Method [KeratinoSens] (OECD 442D)

Study Design of In Vitro Skin Sensitization - ARE-Nrf2 Luciferase Test Method [KeratinoSens] (OECD 442D) The KeratinoSens assay is a...

January 16, 20243 Min read
Read More

Study Design of In Vitro Skin Sensitization [Dermal Peptide Reactivity Assay (DPRA)] (OECD 442C)

Study Design of In Vitro Skin Sensitization [Dermal Peptide Reactivity Assay (DPRA)] (OECD 442C) The Dermal Peptide Reactivity Assay (DPRA)...

January 16, 20243 Min read
Read More

Study Design of In Vitro Eye Irritation EpiOcular (OECD 492) Study Design

Study Design of In Vitro Eye Irritation EpiOcular (OECD 492) Study Design The EpiOcular™ Eye Irritation Test (OECD 492) is...

January 16, 20243 Min read
Read More
medbotics llp

Our Motto

Our ‘Client First’ motto drives us to prioritise regulatory challenges which allow both flexibility for the client and compliance to be a reference of excellence in the global supply of solutions for validation in order to enable regulatory compliance for companies of all sizes.

Vision

Following the best regulatory practices combining our expertise & experience with client’s insights

Mission

To deliver tangible and sustainable results to the clients by innovative proposals, digital transformation, information security and sustainability.

Medbotics LLP

Scroll to Top